title: Alpha1-adrenoceptor-mediated formation of glycerophosphoinositol 4-phosphate in rat heart: possible role in the positive inotropic response.
abstract: In the present study, we investigated whether phospholipase A2 (PLA2)/lysophospholipase activity producing glycerophosphoinositols from phosphoinositides was operating in rat heart and could be stimulated by alpha1-adrenergic agonists. PLA2/lysophospholipase activity was found in homogenates from rat right ventricles. The stimulation of PLA2/lysophospholipase activity by noradrenaline (NA) was prevented either by the alpha1-adrenergic antagonist prazosin or arachidonyl trifluoromethyl ketone, a selective inhibitor of the 85-110 kDa, sn-2-arachidonyl-specific cytosolic PLA2. The selective alpha1-adrenergic agonist phenylephrine induced a concentration- and time-dependent increase in glycerophosphoinositol (GroPIns) and glycerophosphoinositol 4-phosphate (GroPIns4P) in rat right ventricle slices prelabelled with D-myo-[3H]inositol. In electrically driven strips of rat right ventricles, prelabelled with D-myo-[3H]inositol, the positive inotropic effect induced by 20 microM NA in the presence of propranolol was accompanied by the formation of GroPIns and GroPIns4P. The concentration of the formed GroPIns4P (1.33+/-0.12 microM, N = 6) was similar to that previously reported to inhibit the Na+/Ca2+ exchanger in cardiac sarcolemmal vesicles (Luciani S, Antolini M, Bova S, Cargnelli G, Cusinato F, Debetto P, Trevisi L and Varotto R, Biochem Biophys Res Commun 206: 674-680, 1995). These findings show that the stimulation of alpha1-adrenoceptors in rat heart is followed by an increase in the formation of GroPIns4P, which may contribute to the positive inotropic effect of alpha1-adrenergic agonists by inhibition of the Na+/Ca2+ exchanger.
authors.affiliation: Department of Pharmacology, University of Padua, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Debetto
authors.forename: G
authors.initials: G
authors.lastname: Cargnelli
authors.forename: M
authors.initials: M
authors.lastname: Antolini
authors.forename: S
authors.initials: S
authors.lastname: Bova
authors.forename: L
authors.initials: L
authors.lastname: Trevisi
authors.forename: R
authors.initials: R
authors.lastname: Varotto
authors.forename: S
authors.initials: S
authors.lastname: Luciani
mesh_terms: D000322:Adrenergic Agonists / Q000494:pharmacology; D058646:Adrenergic alpha-1 Receptor Agonists; D000818:Animals; D006352:Heart Ventricles / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism*; D008245:Lysophospholipase / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D051381:Rats; D017208:Rats, Wistar; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism*; D010738:Type C Phospholipases / Q000378:metabolism
chemical_list: D000322:Adrenergic Agonists; D058646:Adrenergic alpha-1 Receptor Agonists; D007295:Inositol Phosphates; D018340:Receptors, Adrenergic, alpha-1; C062528:glycero-3-phosphoinositol 4-phosphate; C014575:glycerylphosphoinositol; D010741:Phospholipases A; D054467:Phospholipases A2; D008245:Lysophospholipase; D010738:Type C Phospholipases